Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endogenous cellular poly-tailed small RNAs are a diverse group of RNA molecules characterized by a 3' polyadenosine (poly(A)) tail and often a 5' triphosphate moiety. These RNAs are typically generated as byproducts of RNA metabolism or through the action of non-canonical poly(A) polymerases like TENT4A and TENT4B, which mark them for degradation or stabilization. They function as potent endogenous ligands for the cytosolic sensor RIG-I (Retinoic acid-inducible gene I), which triggers the innate immune system's antiviral response. Under normal physiological conditions, these RNAs are sequestered or rapidly degraded to prevent autoimmunity; however, their accumulation can lead to chronic inflammation or interferonopathies. While they are not traditional therapeutic targets, their role in RIG-I activation makes them significant in the study of autoimmune diseases and the development of synthetic RNA-based immunotherapies for cancer.
Binding and activation of the RIG-I receptor, leading to MAVS-mediated induction of type I interferons and proinflammatory cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous cellular poly-tailed small RNAs.